SCHEMBL25856486

SCHEMBL25856486

CCCCCCCCCCCCCCCC(O)C(CO)N(CCCC)CCCCCCCCOC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SPHK1 Q9NYA1 5/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ CETP P11597 2/20 0.41
▸ GMNN O75496 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ THPO P40225 1/20 0.41
▸ MTOR P42345 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ UBE2N P61088 1/20 0.41
▸ USP2 O75604 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23483288 0.81 CYP2D6 (0.38) SPHK1CYP2D6LMNACETPGMNN
SCHEMBL23954066 0.81 CYP2D6 (0.38) SPHK1CYP2D6LMNACETPGMNN
SCHEMBL18202117 0.81 CYP2D6 (0.38) SPHK1CYP2D6LMNACETPGMNN
SCHEMBL25488820 0.76 CYP2D6 (0.33) SPHK1CYP2D6LMNACETPGMNN
SCHEMBL21636787 0.71 SPHK1 (0.55) SPHK1CYP2D6LMNACETPGMNN
SCHEMBL21428085 0.71 SPHK1 (0.55) SPHK1CYP2D6LMNACETPGMNN
SCHEMBL15057401 0.71 SPHK1 (0.55) SPHK1CYP2D6LMNACETPGMNN
Propylene Glycol SCHEMBL22499994 0.70 USP2 (0.52) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL18885426 0.70 FFAR4 (0.52) HTTUSP2
SCHEMBL8459834 0.70 FFAR4 (0.52) HTTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4212510-A1 NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS Acuitas Therapeutics Inc. (CA) 2023-07-19 — — EP disclosed
Send feedback